Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more

Ventas Reports 2026 Third Quarter Results

By Business Wire | October 27, 2026, 4:10 PM

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2026.



CEO Remarks

“Ventas delivered strong enterprise results and growth in the third quarter, as we executed our 1-2-3 strategy and drove outperformance at scale. Our large and growing Senior Housing Operating Portfolio (“SHOP”) powered the Company’s organic property growth, and we used our differentiated platform, operating expertise and data advantages to generate results that significantly outperformed industry benchmarks,” said Debra A. Cafaro, Ventas Chairman and CEO.

“Additionally, we are aggressively expanding our SHOP business through attractive acquisitions designed to increase our enterprise growth and enhance the Company’s multiyear growth outlook. We have closed over $5 billion of investments focused on U.S. senior housing year to date. We have significant momentum in the market, and we are currently advancing our robust pipeline of actionable SHOP investment opportunities.

“With our commitment to helping people live longer, healthier and happier lives, we are well positioned to serve the secular demand from a wave of Baby Boomers turning 80 over the coming decade.

“We are again raising our full year earnings guidance primarily because of our 2026 investment activity. Our business and team are built to meet this moment, and we are focused on creating value for stakeholders,” Cafaro concluded.

Third Quarter and Other 2026 Highlights

  • Net Income Attributable to Common Stockholders (“Attributable Net Income”) per share of $0.13
  • Normalized Funds From Operations* (“Normalized FFO”) per share of $0.99, an increase of 10% year-over-year
  • Total Company Net Operating Income* (“NOI”) year-over-year growth of 18% and Total Company Same-Store Cash NOI* year-over-year growth of 11%
  • On a Same-Store Cash NOI* basis, SHOP grew 16% year-over-year, led by U.S. growth of 17%
  • Year to date, the Company closed $5.2 billion of investments focused on senior housing with attractive financial return expectations, consistent with its Right Market, Right Asset, Right OperatorTM strategy
  • To fund its 2026 investment activity, year to date through September 30, 2026, the Company settled 47.3 million shares of common stock under equity forward sales agreements for gross proceeds of $3.9 billion; and, at September 30, 2026, the Company had $0.8 billion of unsettled equity forward sales agreements, totaling $4.7 billion in equity capital

*Some of the financial measures throughout this press release are non-GAAP measures. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

Third Quarter 2026 Company Results

For the Third Quarter 2026, reported per share results were:

 

 

Quarter Ended September 30,

 

 

2026

 

2025

 

$ Change

 

% Change

Attributable Net Income

 

$0.13

 

$0.14

 

$(0.01)

 

(7%)

Nareit FFO*

 

$1.01

 

$0.88

 

$0.13

 

15%

Normalized FFO*

 

$0.99

 

$0.90

 

$0.09

 

10%

SHOP Growth

In the third quarter, SHOP Same-Store Cash NOI increased 16% year-over-year. Same-Store revenue per occupied room (“RevPOR”) grew 5% and average occupancy grew 290 basis points year-over-year. Same-Store Cash NOI margin* grew 190 basis points year-over-year, benefitting from favorable operating leverage combined with RevPOR and occupancy growth.

During the third quarter, U.S. SHOP Same-Store Cash NOI increased 17%, and average occupancy grew 320 basis points to exceed 90%, year-over-year.

Investment Activity

Ventas closed $1.2 billion of senior housing investments in the third quarter, and year to date has closed $5.2 billion of investments focused on senior housing. The Company expects these investments to increase its growth rate on a multiyear basis and generate attractive financial returns. The Company’s relationship-based investment momentum continues with a robust investment pipeline that is active and actionable.

Financial Strength and Flexibility

The Company’s Net Debt-to-Further Adjusted EBITDA* strengthened to 4.4x as of the end of the third quarter, representing a continued trend of sequential improvement and nearly a full turn improvement from the prior year period. The improvement was driven by SHOP NOI growth and equity-funded senior housing investments.

As of September 30, 2026, the Company had $4.5 billion in liquidity, supporting Ventas’s growth and financial flexibility. Liquidity includes availability under its unsecured credit facilities, cash and cash equivalents and unsettled equity forward sales agreements outstanding.

Increased Full Year 2026 Guidance

The Company is increasing its guidance for the full year. The Company’s 2026 guidance contains forward-looking statements and is based on a number of assumptions, including those identified later in this press release; actual results may differ materially. Ventas expects to report 2026 per share Attributable Net Income, Nareit FFO and Normalized FFO within the following ranges:

 

 

As of 10/27/26

 

As of 7/29/26

Attributable Net Income Per Share Range

 

$0.64 - $0.67

 

$0.58 - $0.63

Attributable Net Income Per Share Midpoint

 

$0.66

 

$0.61

Nareit FFO Per Share Range*

 

$3.83 - $3.86

 

$3.76 - $3.81

Nareit FFO Per Share Midpoint*

 

$3.85

 

$3.79

Normalized FFO Per Share Range*

 

$3.87 - $3.90

 

$3.85 - $3.90

Normalized FFO Per Share Midpoint*

 

$3.89

 

$3.88

Full Year 2026 Guidance Commentary Update

The increase in the Company’s guidance is primarily the result of 2026 accretive senior housing investment activity, partially offset by the impacts of interest rates and foreign exchange. Certain additional assumptions are set forth in the appendix.

Investor Presentation

An Earnings Presentation is posted to the Events & Presentations section of Ventas’s website at ir.ventasreit.com/events-and-presentations. Additional information regarding the Company can be found in its Supplemental posted at ir.ventasreit.com. The information contained on, or that may be accessed through, the Company’s website, including the information contained in the aforementioned Earnings Presentation and Supplemental, is not incorporated by reference into, and is not part of, this document.

Third Quarter 2026 Results Conference Call

Ventas will hold a conference call to discuss this earnings release on Wednesday, October 28, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (833) 461-5787 (or +1 (585) 542-9983 for international callers), and the participant passcode is 771494992. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (833) 309-1852 (or +1 (929) 828-5978 for international callers), passcode 771494992, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

About Ventas

Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,500 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its approximately 1,000 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Non-GAAP Financial Measures

This press release of Ventas, Inc. (the “Company,” “we,” “us,” “our” and similar terms) includes certain financial performance measures not defined by generally accepted accounting principles in the United States (“GAAP”), such as Nareit FFO, Normalized FFO, Net Operating Income (“NOI”), Cash NOI, Same-Store Cash NOI, Same-Store Cash NOI Margin, Same-Store Cash NOI Growth, Cash Operating Revenue, Same-Store Cash Operating Revenue and Net Debt to Further Adjusted EBITDA. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in the appendix to this press release. Our definitions and calculations of these non-GAAP measures may not be the same as similar measures reported by other REITs.

These non-GAAP financial measures should not be considered as alternatives for, or superior to, financial measures calculated in accordance with GAAP.

Cautionary Statements

Certain of the information contained herein, including intra-quarter operating information, has been provided by our operators and we have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot assure you of its accuracy.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of phrases or words such as “assume,” “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “target,” “forecast,” “plan,” “line-of-sight,” “outlook,” “potential,” “opportunity,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management’s beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled “Cautionary Statements — Summary Risk Factors” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K as we file them with the Securities and Exchange Commission.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, artificial intelligence, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers’, tenants’ and borrowers’ business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic and general economic conditions on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, and the actual and perceived state of the real estate markets and public and private capital markets; (c) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (d) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (e) our ability to identify and consummate future investments in healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (f) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (g) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or lease from, us, which limits our control and influence over such properties, their operations and their performance; (h) our reliance and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (i) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants, borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us; (j) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (k) our exposure to various operational risks, liabilities and claims from our operating assets; (l) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (m) our ownership of properties or operation of business outside of the U.S. that may subject us to different or greater risks than those associated with our domestic operations; (n) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (o) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (p) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets; (q) the risk of exposure to unknown liabilities from our investments in properties or businesses; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (s) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (t) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries’ existing indebtedness; (u) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (v) the risk of potential dilution resulting from future sales or issuances of our equity securities; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risks or uncertainties relating to the use of, or inability to take advantage of, the benefits of artificial intelligence by us or our managers, tenants or borrowers; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers’, tenants’ or borrower’s operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the risk of catastrophic or extreme weather and other natural events; (aa) our ability to attract and retain talented employees; (bb) our ability to maintain a positive reputation for quality and service with our key stakeholders; (cc) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (dd) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (ee) risks and uncertainties related to the UPREIT Reorganization; and (ff) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts; dollars in USD; unaudited)

 

 

 

 

 

As of September 30, 2026

 

As of December 31, 2025

Assets

 

 

 

Real estate investments:

 

 

 

Land and improvements

$

3,390,024

 

 

$

2,962,738

 

Buildings and improvements

 

34,209,438

 

 

 

30,872,598

 

Construction in progress

 

248,737

 

 

 

358,811

 

Acquired lease intangibles

 

2,046,823

 

 

 

1,680,567

 

Operating lease assets

 

314,623

 

 

 

295,838

 

 

 

40,209,645

 

 

 

36,170,552

 

Accumulated depreciation and amortization

 

(12,912,169

)

 

 

(12,043,619

)

Net real estate property

 

27,297,476

 

 

 

24,126,933

 

Secured loans receivable and investments, net

 

442,287

 

 

 

143,913

 

Investments in unconsolidated real estate entities

 

584,905

 

 

 

617,571

 

Net real estate investments

 

28,324,668

 

 

 

24,888,417

 

Cash and cash equivalents

 

202,009

 

 

 

741,067

 

Escrow deposits and restricted cash

 

27,623

 

 

 

45,070

 

Goodwill

 

1,045,824

 

 

 

1,046,072

 

Assets held for sale

 

100,813

 

 

 

42,993

 

Deferred income tax assets, net

 

2,807

 

 

 

2,797

 

Other assets

 

921,638

 

 

 

825,529

 

Total assets

$

30,625,382

 

 

$

27,591,945

 

Liabilities and equity

 

 

 

Liabilities:

 

 

 

Senior notes payable and other debt

$

12,436,652

 

 

$

13,011,016

 

Accrued interest payable

 

97,664

 

 

 

143,104

 

Operating lease liabilities

 

230,568

 

 

 

208,602

 

Accounts payable and other liabilities

 

1,469,788

 

 

 

1,240,820

 

Liabilities related to assets held for sale

 

6,489

 

 

 

4,032

 

Deferred income tax liabilities

 

31,801

 

 

 

23,409

 

Total liabilities

 

14,272,962

 

 

 

14,630,983

 

Redeemable OP unitholder and noncontrolling interests

 

492,756

 

 

 

375,154

 

Commitments and contingencies

 

 

 

Equity:

 

 

 

Ventas stockholders’ equity:

 

 

 

Preferred stock, $1.00 par value; 10,000 shares authorized, unissued

 

—

 

 

 

—

 

Common stock, $0.25 par value; 1,200,000 shares authorized, 528,820 and 474,926 shares outstanding at September 30, 2026 and December 31, 2025, respectively

 

132,205

 

 

 

118,732

 

Capital in excess of par value

 

23,834,762

 

 

 

19,976,183

 

Accumulated other comprehensive loss

 

(23,689

)

 

 

(39,851

)

Retained earnings (deficit)

 

(8,136,215

)

 

 

(7,527,777

)

Treasury stock, 0 shares issued

 

—

 

 

 

(34

)

Total Ventas stockholders’ equity

 

15,807,063

 

 

 

12,527,253

 

Noncontrolling interests

 

52,601

 

 

 

58,555

 

Total equity

 

15,859,664

 

 

 

12,585,808

 

Total liabilities and equity

$

30,625,382

 

 

$

27,591,945

 

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts; dollars in USD; unaudited)

 

 

 

 

 

 

 

 

 

For the Three Months Ended September 30,

 

For the Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Revenues

 

 

 

 

 

 

 

Rental income:

 

 

 

 

 

 

 

Triple-net leased properties

$

129,484

 

 

$

160,050

 

$

377,411

 

 

$

468,865

Outpatient medical and research portfolio

 

233,239

 

 

 

226,200

 

 

 

691,948

 

 

 

668,333

 

 

 

362,723

 

 

 

386,250

 

 

 

1,069,359

 

 

 

1,137,198

 

Resident fees and services

 

1,450,802

 

 

 

1,088,546

 

 

 

4,107,090

 

 

 

3,090,164

 

Third-party capital management revenues

 

4,140

 

 

 

4,492

 

 

 

12,796

 

 

 

13,225

 

Income from loans and investments

 

12,165

 

 

 

5,524

 

 

 

22,866

 

 

 

14,243

 

Interest and other income

 

1,961

 

 

 

4,184

 

 

 

6,238

 

 

 

13,133

 

Total revenues

 

1,831,791

 

 

 

1,488,996

 

 

 

5,218,349

 

 

 

4,267,963

 

Expenses

 

 

 

 

 

 

 

Interest

 

161,388

 

 

 

158,124

 

 

 

477,564

 

 

 

457,778

 

Depreciation and amortization

 

446,013

 

 

 

357,173

 

 

 

1,236,192

 

 

 

1,026,417

 

Property-level operating expenses:

 

 

 

 

 

 

 

Senior housing

 

1,020,832

 

 

 

786,250

 

 

 

2,899,163

 

 

 

2,236,952

 

Outpatient medical and research portfolio

 

80,529

 

 

 

79,136

 

 

 

238,611

 

 

 

230,094

 

Triple-net leased properties

 

3,201

 

 

 

3,012

 

 

 

9,244

 

 

 

10,505

 

 

 

1,104,562

 

 

 

868,398

 

 

 

3,147,018

 

 

 

2,477,551

 

Third-party capital management expenses

 

1,794

 

 

 

1,517

 

 

 

5,333

 

 

 

4,969

 

General, administrative and professional fees

 

47,698

 

 

 

40,387

 

 

 

157,430

 

 

 

136,392

 

Loss on extinguishment of debt, net

 

14

 

 

 

119

 

 

 

546

 

 

 

119

 

Transaction, transition and restructuring costs

 

7,872

 

 

 

5,472

 

 

 

28,009

 

 

 

16,081

 

Other expense

 

9,821

 

 

 

13,370

 

 

 

23,975

 

 

 

20,621

 

Total expenses

 

1,779,162

 

 

 

1,444,560

 

 

 

5,076,067

 

 

 

4,139,928

 

Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests

 

52,629

 

 

 

44,436

 

 

 

142,282

 

 

 

128,035

 

(Loss) income from unconsolidated entities

 

(5,464

)

 

 

16,644

 

 

 

(20,626

)

 

 

12,195

 

Gain on real estate dispositions

 

815

 

 

 

1,283

 

 

 

16,037

 

 

 

35,268

 

Income tax benefit

 

19,301

 

 

 

6,345

 

 

 

60,856

 

 

 

13,028

 

Net income

 

67,281

 

 

 

68,708

 

 

 

198,549

 

 

 

188,526

 

Net income attributable to noncontrolling interests

 

1,901

 

 

 

2,661

 

 

 

6,687

 

 

 

7,347

 

Net income attributable to common stockholders

$

65,380

 

 

$

66,047

 

 

$

191,862

 

 

$

181,179

 

Earnings per common share

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

Net income

$

0.13

 

 

$

0.15

 

 

$

0.40

 

 

$

0.42

 

Net income attributable to common stockholders

 

0.13

 

 

 

0.14

 

 

 

0.39

 

 

 

0.40

 

Diluted:

 

 

 

 

 

 

 

Net income

$

0.13

 

 

$

0.15

 

 

$

0.40

 

 

$

0.41

 

Net income attributable to common stockholders

 

0.13

 

 

 

0.14

 

 

 

0.38

 

 

 

0.40

 

Weighted average shares used in computing earnings per common share

 

 

 

 

 

 

 

Basic

 

513,946

 

 

 

456,032

 

 

 

493,324

 

 

 

449,572

 

Diluted

 

518,937

 

 

 

463,415

 

 

 

501,284

 

 

 

456,392

 


Contacts

BJ Grant
(877) 4-VENTAS


Read full story here

Mentioned In This Article

Latest News